Anlotinib to Malignant Brainstem Glioma
NCT04668508
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Malignant Brain Stem Tumor
Glioma
Interventions
DRUG:
Anlotinib
Sponsor
Zhejiang Cancer Hospital